Fri, Sep 24, 2:15 PM - 3:30 PM
Virtual
Recent Development in the Evaluation of COVID-19 Vaccines, Treatments & Tests
Panel Discussion (303554)
*
Joseph Briggs, FDA/CDRH
*
Lori Dodd, National Institutes of Health
*
Dean Follmann, NIH/NIAID
*
Michael Hudgens, University of North Carolina, Chapel-Hill
